Afuco™ Anti-EGFR ADCC Therapeutic Antibody (Matuzumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to EGFR. Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR) with high affinity. The mouse monoclonal antibody (mAb425).
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-165 |
| Pricing | Inquiry |
| Host | Human |
| Target | EGFR |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | Neut, ELISA, IF, IP, FuncS, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |